Dutch unit to collaborate in biomass-ethanol project
© Hans

Dutch unit to collaborate in biomass-ethanol project

An American firm has announced the participation of its Dutch unit in a new advanced biofuels project funded by Horizon 2020.

Dyadic International Inc., based in Florida in the United States, said Dyadic Netherlands would work in collaboration with Compagnie Industrielle de Matiere Vegetale and five other industry partners to develop, construct and operate a large demonstration-scale facility that produces ethanol from biomass as part of the 2G BIOPIC project.

Detailing the project, Dyadic’s chief operating officer, Danai Brooks, commented: “We are pleased to continue working closely with CIMV, and believe that Dyadic’s C1 enzymes will play a critical role in the 2G BIOPIC project success.

“The aim of 2G BIOPIC is to demonstrate the performance, reliability and sustainability of producing bioethanol from agriculture waste and wood. The demonstration plant built in the 2G BIOPIC programme will process one tonne of biomass per hour, or about 50 times the size of the CIMV pilot plant upon which the project is based. Successful funding of the 2G BIOPIC programme further highlights the strength of Dyadic’s C1 Expression System in the field of advanced biofuels.”

The grant provides that Dyadic Netherlands will be paid a total of approximately €1m over the three year term of the project. Adding his thoughts, Dr Wim van der Wilden, general manager of Dyadic Netherlands, said: “Using our patented and proprietary C1 technology platform, we have been able to dramatically reduce costs and improve efficacy of our product line, which is now on its fifth generation – CMAX®5. In the 2G BIOPIC project, we expect to tailor our commercial CMAX® enzyme to 2G BIOPIC’s pretreated biomass feedstock to further increase enzyme effectiveness and reduce costs.”

Dyadic is a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries.